Loading clinical trials...

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT03456830

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria

The purpose of this study is to determine the efficacy and safety of ALLN-177 in patients with enteric hyperoxaluria.

Lead sponsor: Allena Pharmaceuticals•39 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1

Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria

NCT04629170 · Healthy, Enteric Hyperoxaluria

TERMINATEDPhase 1/2

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

NCT04909723 · Healthy Volunteers, Enteric Hyperoxaluria

UNKNOWNPhase 1

Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria

NCT05650112 · Healthy, Enteric Hyperoxaluria

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 27, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment115

Start dateMay 2018

Last updatedFeb 27, 2020

Condition

Enteric Hyperoxaluria

Locations shown

Urology Centers of Alabama

Birmingham, Alabama

University of Alabama, Department of Urology

Birmingham, Alabama

Mayo Clinic Hospital

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 27, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions